A detailed history of Copley Financial Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Copley Financial Group, Inc. holds 4,733 shares of ABT stock, worth $585,093. This represents 0.48% of its overall portfolio holdings.

Number of Shares
4,733
Previous 5,393 12.24%
Holding current value
$585,093
Previous $715 Million 10.02%
% of portfolio
0.48%
Previous 0.55%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

SELL
$123.95 - $138.08 $81,807 - $91,132
-660 Reduced 12.24%
4,733 $644 Million
Q1 2025

Jul 08, 2025

SELL
$111.1 - $140.22 $19,998 - $25,239
-180 Reduced 3.23%
5,393 $715 Million
Q1 2025

Jun 27, 2025

SELL
$111.1 - $140.22 $11,998 - $15,143
-108 Reduced 1.9%
5,573 $630 Million
Q3 2024

Dec 09, 2024

BUY
$100.07 - $118.13 $568,497 - $671,096
5,681 New
5,681 $648 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $216B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Copley Financial Group, Inc. Portfolio

Follow Copley Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copley Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Copley Financial Group, Inc. with notifications on news.